trial · primary record
Nipocalimab
Sjogrens Syndrome
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 655 |
| Primary completion | 2029-05-18 |
| Primary endpoint | Change from Baseline in Clinical European League Against Rheumatism Sjogren's Syndrome Disease Activity Index (ClinESSDAI) Score at Week 48 |
| Registry ID | NCT06741969 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:02.787Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06741969
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nipocalimab · compound